共 58 条
[1]
Bonadonna G(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials Lancet 365 1687-1717
[2]
Valagussa P(1995)Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up N Engl J Med 332 901-906
[3]
Moliterni A(1994)Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma N Engl J Med 330 1253-1259
[4]
Wood WC(1998)Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer J Natl Cancer Inst 90 1205-1211
[5]
Budman DR(2000)The impact of chemotherapy dose density and dose intensity on breast cancer outcome: what have we learned? Eur J Cancer 36 S4-S10
[6]
Korzun AH(2000)Chemotherapy dose reduction and delay in clinical practice: evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer Eur J Cancer 36 S11-S14
[7]
Budman DR(2000)Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup trial C9741/Cancer and Leukemia Group B trial 9741 NIH Consensus Statement 17 1-35
[8]
Berry DA(2003)Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices J Clin Oncol 21 1431-1439
[9]
Cirrincione CT(2003)Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin’s lymphoma: a nationwide study J Clin Oncol 21 4524-4531
[10]
Piccart MJ(2004)Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized clinical trials J Clin Oncol 22 4302-4311